Clinical Trial Investigator in Chordate’s study in chronic migraine
Chordate Medical’s patient study PM007 is completed and the results indicate that Kinetic Oscillation Stimulation is an effective and safe treatment for chronic migraine. One of the Clinical Trial Investigators in the study is Emilia Tauriala, specialist in neurology and CMO at Terveystalo. Emilia joined BioStock’s studio to tell us more about the study design and results. In addition, we got to take part of her view on K.O.S and the benefits compared to current treatments.
Watch the interview with Emilia Tauriala about Chordate Medical below.
Read more about Chordate Medical on the company’s website.
The content of BioStock’s news and analyses is independent but the work of BioStock is to a certain degree financed by life science companies. The above article concerns a company from which BioStock has received financing.
